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Abstract
Optic neuritis is a common manifestation of multiple sclerosis, an inflammatory demyelinating
disease of the CNS. Although it is the presenting symptom in many cases, the initial events are
currently unknown. However, in the earliest stages of autoimmune optic neuritis in rats, patho-
logical changes are already apparent such as microglial activation and disturbances in myelin
ultrastructure of the optic nerves. αB-crystallin is a heat-shock protein induced in cells undergo-
ing cellular stress and has been reported to be up-regulated in both multiple sclerosis and its ani-
mal model, experimental autoimmune encephalomyelitis. Therefore, we wished to investigate
the timing and localization of its expression in autoimmune optic neuritis. Although loss of oligo-
dendrocytes was not observed until the later disease stages accompanying immune cell infiltra-
tion and demyelination, an increase in oligodendrocyte αB-crystallin was observed during the
preclinical stages. This was most pronounced within the optic nerve head and was associated
with areas of IgG deposition. Since treatment of isolated oligodendrocytes with sera from mye-
lin oligodendrocyte glycoprotein (MOG)-immunized animals induced an increase in αB-crystallin
expression, as did passive transfer of sera from MOG-immunized animals to unimmunized recip-
ients, we propose that the partially permeable blood–brain barrier of the optic nerve head may
present an opportunity for blood-borne components such as anti-MOG antibodies to come into
contact with oligodendrocytes as one of the earliest events in disease development.
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1 | INTRODUCTION
Optic neuritis is a common first presenting symptom of the autoimmune
condition of multiple sclerosis (MS) occurring in about 25% of cases
(Toosy, Mason, & Miller, 2014); and following an initial diagnosis of clini-
cally isolated syndrome, it can be a major prognostic for subsequent
progression to clinically definite MS (Miller, Barkhof, Montalban, Thomp-
son, & Filippi, 2005). Optic neuritis, defined as inflammation of the optic
nerves leading to visual impairment, is characterized by immune cell infil-
tration and subsequent demyelination. It can be modeled in rodents
such as Brown Norway (BN) rats that are immunized with myelin
oligodendrocyte glycoprotein (MOG) (Meyer et al., 2001; Stefferl et al.,
1999; Storch et al., 1998). These animals, after a delay of around 12 days
in which the immune response evolves, develop spinal cord symptoms
typical of experimental autoimmune encephalomyelitis (EAE), with con-
current optic nerve inflammation. BN rats also have a strong anti-MOG
antibody response (Stefferl et al., 1999), which may also demonstrate the
relevance of this model for other neurological diseases such as pediatric
MS, subgroups of neuromyelitis optica and cases of anti-NMDA-receptor
encephalitis where such antibodies are present (Havla et al., 2017).
We have previously reported that one of the key parameters of
BN rat autoimmune optic neuritis (AON), namely degeneration of
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retinal ganglion cells whose axons comprise the optic nerve, is not
only prevalent but also precedes immune cell infiltration of the optic
nerves by several days (Fairless et al., 2012; Hobom et al., 2004).
However, the early disease processes occurring during this preclinical
stage are currently not fully understood, although increased numbers
of activated microglia residing in both the retina and optic nerves have
been detected.
To investigate the preclinical disease pathology in more detail,
we have investigated the expression of αB-crystallin, a member of
the small heat shock family of proteins, as a marker of cellular stress.
Previous studies of autoimmune demyelinating diseases have
reported that its expression is robustly up-regulated both in MS
(Bajramovic et al., 2000; Peferoen et al., 2015) and EAE (Chabas
et al., 2001; Ousman et al., 2007). In particular, αB-crystallin has
been reported to be expressed early during MS pathology, being
observed within both developing lesions (Bajramovic, Lassmann, &
van Noort, 1997) and in the normal-appearing white matter (Van
Noort et al., 2010), where it may represent an early stress response.
Due to the similarities of the preactive lesion with the pathology of
optic nerves during the preclinical stage of AON, namely microglial
activation in the absence of demyelination and leukocyte infiltration,
we wished to determine whether αB-crystallin is similarly expressed
in the optic nerves of MOG-immunized BN rats, and whether, as an
early marker of stress, it can help reveal the anatomy of vulnerability
within the optic system.
2 | MATERIALS AND METHODS
2.1 | Animals
Female Brown Norway (BN, RRID:RGD_737972) rats (8–10 weeks
old), used for MOG-EAE experiments, and Sprague Dawley (SD, RRID:
RGD_734476) rat pups (postnatal day two; P2), for cultures of primary
glial cells, were obtained from Charles River (Sulzfeld, Germany) and
kept under environmentally controlled conditions in the absence of
pathogens with free access to food and water. All experiments that
involved animal use were performed in compliance with the relevant
laws and institutional guidelines of Baden–Württemberg.
2.2 | Induction and evaluation of MOG-EAE
BN rats were immunized with whole recombinant rat MOG (a kind gift
of Prof. Christine Stadelmann, Department of Neuropathology, Uni-
versity of Göttingen). Rats were injected intradermally at the base of
the tail with an emulsion (200 μl) containing 100 μg MOG in saline
mixed 1:1 with complete Freund's adjuvant (CFA; Sigma-Aldrich,
St. Louis, MO) containing 200 μg of heat-inactivated Mycobacterium
tuberculosis H37RA (Difco Microbiology, Lawrence, KS). Sham-
immunized rats received the same volume of emulsion but without
MOG, and together with healthy animals served as controls. Unless
indicated otherwise, sham animals were taken at 14 days post immu-
nization. Rats were scored daily for clinical signs of EAE as previously
described (Meyer et al., 2001).
2.3 | Passive sera transfer and depletion of anti-
MOG antibodies
Blood was collected from donor rats (MOG or sham-immunized) by
heart puncture and stored overnight at 4 C to coagulate. Sera were
then isolated by centrifugation (15,000g for 15 min at 4 C) and a
sample was taken for MOG-ELISA analysis, before concentration by
further centrifugation using Amicon® Ultra 15 ml centrifugal filters
(3 kDa membrane; Millipore, Darmstadt, Germany) at 3000g at 4 C
to achieve a volume of approximately 1,000 μl per donor rat. Con-
centrated sera was then injected intravenously via the tail vein of
naïve recipient BN rats under isofluorane anesthesia at day 0 and
then a repeat injection was given on day 3 post-serum-transfer (pst).
Blood samples were collected from recipient animals prior to and at
days 1, 3, and 5 pst. At day 5 pst, blood was collected by heart punc-
ture, and animals were perfused with 4% paraformaldehyde (PFA).
To deplete the sera of anti-MOG antibodies, cyanogen bromide-
activated Sepharose 4B (GE Healthcare, Chicago, IL) was used accord-
ing to the manufacturer's instructions. Briefly, Sepharose 4B was
coupled to rat recombinant MOG protein by overnight incubation at
4 C in coupling buffer (0.2 M NaHCO3, 0.5 M NaCl, pH 8.3) with sub-
sequent washing and blocking of unreacted binding sites. MOG-
coupled Sepharose was then recovered by centrifugation at 3000g for
5 min before incubation with sera (using the following ratios: 268 mg
Sepharose 4B coupled to 1.5 mg MOG per 1.6 ml of sera) for 1 hr at
4 C. The resin was subsequently removed from sera by centrifugation
at 3000g for 5 min. Successful depletion of anti-MOG antibodies from
EAE sera was confirmed by both ELISA and immunostaining of mature
oligodendrocyte cultures.
2.4 | Cell culture of primary oligodendrocytes
Primary oligodendrocytes were isolated from cortices of P2 SD pups
using commercial anti-O4-coated magnetic beads and separation
columns (Miltenyi Biotec, Bergisch Gladbach, Germany). Briefly,
brains were dissected and meninges were removed before isolation
of cortices which were mechanically disrupted and dissociated using
5% trypsin (Sigma-Aldrich) and 500 U DNase 1 (Roche, Mannheim,
Germany) before purification according to the manufacturer's
instructions. The O4-positive cell fraction was then seeded on either
poly-D-lysine (PDL, Sigma-Aldrich)-coated 6-well plates (100,000
cells/well for lysates) or 24-well plates (10,000 cells/well for immu-
nocytochemistry). Cells were grown for 7 days in proliferation
medium before switching to differentiation medium for an additional
week. Proliferation media consisted of a basic media (RPMI 1640
medium supplemented with 1% Sato's medium, 1% bovine pancreas
insulin (0.5 mg/ml; Sigma), 1% Na-pyruvate (100 mM; Sigma-
Aldrich), 2% L-glutamine (2 mM; Sigma-Aldrich) and 1% Pen-Strep
(10,000 U/ml; Gibco), supplemented with 0.1% platelet-derived
growth factor (PDGF, rat recombinant, 10 ng/ml; R&D systems,
Minneapolis, MN) and 0.15% basic fibroblast growth factor (bFGF,
human recombinant, 10 ng/ml; PeproTech Inc., Rocky Hill, NJ). Dif-
ferentiation medium consisted of basic medium supplemented with
0.1% ciliary neurotrophic factor (CNTF, rat recombinant, 10 ng/ml;
PeproTech Inc.), 0.1% N-acetyl-L-cysteine (3 mg/ml; Sigma) and 1%
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triiodothyronine (T3, 15 nM; Sigma-Aldrich). Purity of resultant cul-
tures was assessed by Olig2 staining (with average purity greater
than 75%), and differentiation status was identified both morpholog-
ically and using antibodies against MOG and CNPase.
Treatment of oligodendrocytes to induce stress was performed
with either 100 μM H2O2, 100 μM Sin-1 or isolated sera diluted as
indicated. Following 90 min exposure, cells were washed and left to
recover overnight in fresh media before fixation and immunostaining.
To assess cell survival and the generation of reactive oxygen
species, commercial kits (LIVE/DEAD Fixable Dead cell stain kit and
CellROX Green Reagent, respectively, both from Thermo Fischer Sci-
entific, Waltham, MA) were used according to the manufacturer's
instructions.
2.5 | Optic nerve histopathology
Following perfusion of rats with 4% PFA, optic nerves with attached
eyes were carefully dissected to maintain an intact optic nerve head.
Tissue was postfixed overnight, cryoprotected in 30% sucrose
(Applichem GmbH, Darmstadt, Germany) in PBS overnight, and then
frozen in Cryoblock embedding medium (Medite, Burgdorf, Germany)
using isopentane (Acros Organics BVBA, Geel, Belgium) cooled with
liquid nitrogen. Eight micrometers thick longitudinal sections were cut
using a cryostat (Leica, Wetzlar, Germany) at −20 C, and sections
transferred to SuperFrost® Plus microscope slides (Thermo Fischer
Scientific,) before storage at −20 C. Demyelination of optic nerves
was assessed using Luxol-fast blue (LFB) staining with hematoxylin
counter-staining, and immunohistochemistry was performed as
described below.
2.6 | Immunolabeling
For immunohistochemistry, antigen retrieval was performed on
optic nerve sections where necessary (Olig2, MBP, and αB-crystal-
lin) by incubation in heated (~80 C) 0.2% citrate buffer (pH 6.0) for
15 min, before being left to cool. For immunocytochemistry, cells
were permeablized with either 0.1% Tween 20 in PBS for detection
of cellular antigens, or with 0.1% Triton X-100 in PBS for nuclear
antigens (i.e., Olig2). Blocking was then performed using 10% nor-
mal goat serum before overnight incubation with primary anti-
bodies at 4 C. The following primary antibodies were used: olig2
(1:500; Millipore, Cat# AB9610, RRID: AB_570666); αB-crystallin
(1:1000; clone 1B6.1-3G4; Abcam, Cambridge, UK, Cat# ab13496,
RRID: AB_300400); GFAP (1:500; Sigma-Aldrich, Cat# G9269, RRID:
AB_477035); Iba-1 (1:1000; Wako Chemicals, Neuss, Germany, Cat#
019–19,741, RRID: AB_839504); MBP (1:300; Sigma-Aldrich, Cat#
M3821, RRID: AB_1841021); MOG (1:500; clone 8-18C5; Millipore,
Cat# MAB5680, RRID: AB_1587278) and CNPase (1:200, BioLegend,
San Diego, CA, Cat# 836404; RRID: AB_2566639). Appropriate sec-
ondary antibodies were then used (anti-mouse Cy3, 1:400, Jackson
ImmunoResearch Laboratories, West Grove, PA, Cat# 115–165-166,
RRID: AB_143165; anti-rabbit A488, 1:400, Thermo Fischer Scien-
tific, Cat# A-11008, RRID: AB_143165) before mounting in anti-fade
Vectashield Mounting Medium (Vector Laboratories, Burlingame,
CA) containing 40,6-diamidino-2-phenylindole (DAPI).
To immunolabel oligodendrocyte cultures with harvested sera,
sera were added to the culture media at 1% and incubated for 30 min
at 37 C before washing and fixation. Subsequently cells underwent
the same staining procedure as outlined above.
IgG antibody deposition in the optic nerves was visualized by
incubation in a biotinylated goat anti-rat secondary antibody (1:200,
Vector Laboratories, Cat# BA-4001, RRID: AB_10015300), followed
by streptavidin-Alexafluor 555 (1:700, Thermo Fischer Scientific,
Cat# S32355, RRID: AB_2571525). For terminal dUTP nick end
labeling (TUNEL) staining, a protocol was used as previously
reported (Stojic et al., 2017), with subsequent co-staining with anti-
bodies being applied afterward.
Fluorescent microscopy and image acquisition were performed
using either a conventional Nikon Eclipse 80i microscope (Nikon
GmbH, Düsseldorf, Germany) or a LSM 700 confocal microscope
(Zeiss, Oberkochen, Germany).
2.7 | Western blotting
Optic nerve lysates were prepared by mechanical homogenization
with ice-cold lysis buffer (50 mM Tris HCl, 150 mM NaCl and 1% Tri-
ton X-100) containing Complete Protease Inhibitor Cocktail (Roche),
and sonicated for 5 s before clarification by centrifugation. About
50 μg of total protein were loaded onto a 4–20% gradient Mini-
PROTEAN® TGX Stain-Free™ Precast gels (BioRad, Hercules, CA) and
separated by SDS-PAGE.
Primary oligodendrocyte lysates were prepared from cultures fol-
lowing 90 min treatment with experimental serum diluted in culture
media as indicated, followed by washing with PBS and 16 hr recovery
in culture media before addition of ice-cold lysis buffer. Cells were
scraped off and sonicated for 10 s before clarification. About 30 μg of
total protein were loaded onto a 3–15% gradient Mini-PROTEAN®
TGX Stain-Free™ Precast gels (BioRad) and separated by SDS-PAGE.
Proteins were subsequently transferred to a polyvinylidene
difluoride membrane for labeling with appropriate antibodies. For
αB-crystallin detection, blocking was performed in 5% BSA and 0.1%
Tween 20 in TBS, and incubated in anti-αB-crystallin primary anti-
body (1:1000; clone 1B6.1-3G4; Abcam, Cat# ab13496, RRID:
AB_300400), whereas for glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH) detection, blocking was performed in 5% milk powder
and 0.1% Tween 20 in TBS, and incubated in anti-GAPDH antibody
(1:2000; clone 6C5, Millipore, Cat# MAB374, RRID: AB_2107445).
Visualization was performed using sheep anti-mouse HRP-conjugated
secondary antibody (1:5000; GE Healthcare, Cat# NA931, RRID:
AB_772210), followed by ECL Prime reagent (Amersham, Bucks, UK)
and imaged using a ChemiDoc XRS+ Imaging System (BioRad).
2.8 | MOG ELISA
To measure titers of anti-MOG antibodies in sera samples, an
enzyme-linked immunosorbent assay (ELISA) was performed. A
96-well PVC plate was coated by overnight incubation (4 C) with the
same whole recombinant MOG used for immunization (0.5 μg/ml).
After blocking with 1% BSA, wells were incubated in duplicate with
sera diluted between 1:1,000 and 1:100,000 in 1% BSA in PBS for
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2 hr at room temperature. After washing with PBS, incubation with
HRP-conjugated goat anti-rat IgG polyclonal antibodies (1:5000; GE
Healthcare, Chicago, IL, Cat# NA931, RRID: AB_772210) was per-
formed for 2 hr at RT, followed by reaction with tetramethylbenzidine
(TMB) substrate (eBioscience, San Diego, CA) for 15 min at RT. The
reaction was then arrested by the addition of 0.16 M H2SO4, and
absorbance was measured at 450 nm. Pseudo-quantification of sera
anti-MOG titers was achieved by comparison of all samples to a com-
mercial anti-MOG antibody (AnaSpec Inc., San Jose, CA; EGT Group
Cat# 55914, RRID: AB_10730308), and use of sera dilutions falling
within the linear range of the ELISA assay.
2.9 | Cell-based anti-MOG antibody assay
Anti-MOG antibodies were determined using a cell-based assay with
MOG transfected HEK293 cells. Briefly, HEK293 cells were trans-
fected with either pcDNA™6.2/C-EmGFP-GW/TOPO™ expression
plasmid (Invitrogen, Karlsruhe, Germany) containing full-length
human MOG or pcDNA™6.2/C-EmGFP-GW/TOPO™ only (empty
vector [EV], control). Surface expression of MOG was verified by
flow cytometry and confocal microscopy with the anti-MOG mono-
clonal antibody 8-18C5 in combination with the secondary
APC-labeled goat anti-mouse IgG antibody (BioLegend). For the
detection of MOG-specific antibodies in rat sera, cells were incu-
bated for 15 min on ice with rat sera diluted 1:400 in the growth
medium. Cells were subsequently washed three times with wash
buffer (PBS plus 2% FBS) and APC-labeled goat anti-rat IgG antibody
(1:200, Invitrogen) was added for 15 min on ice, followed by two
additional washing steps. Median fluorescence intensity (MFI) was
analyzed on a FACS Canto (BD Bioscience; San Jose, CA) and the
MFI ratio of HEKMOG versus HEKEV was calculated and plotted using
GraphPad Prism® software.
2.10 | Knockdown of αB-crystallin
Predesigned 29-mer shRNA-containing retroviral vectors were pur-
chased from OriGene (Rockville, MD) containing either the αB-crystallin-
specific sequence (50–30) AGATGCGTATGGAGAAGGACAGGTTCTCT
(Catalog Nr. TG709545) or a noneffective scrambled sequence
(Catalog Nr. TR30013). Lentiviral particles were generated in HEK
293LTV cells using a Lenti-vpak packaging kit (OriGene; Catalog
Nr. TR30037). Oligodendrocyte cultures were infected 4 days after
switching from proliferation to differentiation media with a 1:100
dilution of lentivirus in media and left for a further 12 days until
experiments were performed.
FIGURE 1 Optic nerve oligodendrocyte apoptosis begins at onset of clinical EAE. Representative images of optic nerves following LFB-staining
of myelin (blue) from (a) healthy, (b) 10 days post immunization (p.i.) and (c) animal on first day of EAE onset. Representative
immunohistochemical images of TUNEL-labeled optic nerves from (d) healthy, (e) day 10 p.i., and (f ) day 1 of EAE (TUNEL, red; counterstained
with Olig2 [green] to identify oligodendrocytes). Apoptotic oligodendrocytes could only be observed within the inflamed optic nerve at day 1 of
EAE (f, and enlarged region in f'). (g) Quantification of TUNEL-positive Olig-2-positive cells throughout the optic nerves (n = 6 optic nerves per
time-point). (h) A typical EAE time-course of MOG-immunized animals, with day 10 p.i. time-point indicated (n = 4). Scale bars in (a) 50 μm and
(d) 100 μm. *p < .01 compared to healthy, ANOVA
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2.11 | RNA isolation, cDNA synthesis, and
quantitative real-time PCR
Total RNA was extracted from dissected optic nerve heads and distal
optic nerves (segments of approximately 1 mm in length) using RNeasy
Plus Micro Kit (Qiagen, Hilden, Germany) and then transcribed into
cDNA using First Strand cDNA Synthesis Kit (Roche) with oligo(dT)
primers. Quantitative Real-Time PCR was subsequently performed
using an ABI 7300 thermal cycler (Applied Systems, University Park, IL)
with RT2 SYBR Green ROX mastermix (Qiagen). Relative quantification
of gene expression was determined by comparison of threshold
values, normalized to β-actin, calculated by 2(−ΔΔCt). The following
primers were used: αB-crystallin—forward 50-GACCGGCTAACCGACTC-
TAC-30 , reverse 50-GGTGCTCTCCGAAGAACTGG; β-actin—forward
50-CTCTGTGTGGATTGGTGGCT-30, reverse 50-GGGTGTAAAACG-
CAGCTCAG-30.
2.12 | Statistical analyses
All data are presented  SEM. Statistical comparisons were made
using SigmaPlot 13 (Systat Software GmbH, San Jose, CA). For com-
paring two experimental groups, data were assessed for normality
using the Shapiro–Wilk Test, followed by either a two-tailed Student's
t test or by Mann–Whitney rank sum test. Multiple experimental
groups were analyzed using one-way analysis of variance (ANOVA)
with post hoc Dunnett's test. A p value of <.05 was considered to be
statistically significant.
3 | RESULTS
3.1 | αB-Crystallin expression is up-regulated during
the preclinical phase of autoimmune optic neuritis
AON is characterized by immune cell infiltration and demyelination of
the optic nerves which typically occurs, in BN rats immunized with
MOG, from around 12 days following disease induction, and corre-
lates with the onset of spinal cord symptoms associated with EAE.
However, it is known that degenerative and pathological changes
within the optic system begin prior to the onset of AON/EAE (Fairless
et al., 2012). To confirm that lesion formation and loss of oligodendro-
cytes within the optic nerve conformed to this time-course LFB stain-
ing was performed to visualize the myelin. No loss of myelin was
FIGURE 2 αB-crystallin expression increases throughout course of AON. (a) Western blot of optic nerve lysates from different time points
throughout time-course of AON using antibodies against αB-crystallin (cryαB) and GAPDH. (b) Quantification revealed a two-fold increase in
cryαB starting already during the late induction phase of AON (day 10 p.i.; n = 4 pooled optic nerves per time point). (c–h) Immunostaining
against cryαB with counterstaining for different glial cell markers, performed on optic nerve sections from healthy (c–e) and animals from day 1 of
EAE (f–h). CryαB-positive staining was mostly associated with oligodendrocytes (Olig2+ cells; c and f ), whereas only modest co-localization could
be observed with GFAP+ astrocytes (d and g, blue inserts). No co-localization could be observed with Iba-1, a marker for microglia/macrophages
(e and h). **p < .01 compared to healthy; and #p < .05, ##p < .01 compared to sham, ANOVA). Scale bar = 100 μm
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observed within the preclinical phase (day 10 post immunization;
Figure 1b), but wide-spread demyelination was apparent on the first
day that clinical EAE symptoms were observed (day 13.64  0.68;
Figure 1c), correlating with immune cell infiltration indicated by the
hyper-cellularity revealed by hematoxylin nuclear staining. Next, apo-
ptosis of oligodendrocytes was investigated by co-staining optic
nerves sections with an antibody against the oligodendrocyte marker
Olig2 in combination with TUNEL staining. No TUNEL positive cells
were observed during the preclinical disease stages but were apparent
at day 1 of EAE (Figure 1f,g; 34.93  10.62, p = .002, ANOVA). In
general, there were fewer Olig2-positive cells distributed along day
1 EAE optic nerves, presumably resulting from a loss of oligodendro-
cytes at disease onset. However, many of those that were detectable
were clustered in regions of TUNEL-positivity (Figure 1f0) indicating
areas of active tissue damage.
Next, the expression of the heat-shock protein, αB-crystallin was
investigated. αB-Crystallin has been reported to be elevated in models
of ischemia or neuroinflammation, such as stroke and EAE (Arac et al.,
2011; Ousman et al., 2007), and also in MS (Bajramovic et al., 1997;
Van Noort et al., 2010). Since its accumulation in MS lesions was
reported in preactive lesions which have been proposed to represent
a stage in early lesion formation, we wished to determine the time-
course of αB-crystallin expression during AON. Western blot analysis
of optic nerve lysates revealed that αB-crystallin expression increases
as the disease progresses, becoming significantly elevated by day
10 post immunization (Figure 2b, healthy = 0.38  0.05, day
10 = 0.81  0.08 relative to GAPDH, p = .002 compared to healthy,
ANOVA) during the preclinical disease phase. To determine in which
cell type αB-crystallin was expressed, co-staining of optic nerve tissue
sections was performed with antibodies against αB-crystallin in com-
bination with markers against oligodendrocytes (Olig2), astrocytes
(GFAP), and microglia/macrophages (Iba1). Expression was primarily
seen in oligodendrocytes and also in some astrocytes, but not in
microglia/macrophages (Figures 2c–e). In later disease stages, these
same cell types were still responsible for expression, although αB-
crystallin expression was more pronounced.
FIGURE 3 αB-crystallin expression increases predominately in the optic nerve head during AON. (a) Longitudinal histochemical staining (LFB) of
a healthy optic nerve, indicating regions of the optic nerve head (ONH) and distal optic nerve (OND) assessed in further detail. Example images of
(b–d) the optic nerve head and (e–g) the distal optic nerve from (b, e) healthy, (c, f ) day 10 p.i., and (d, g) animals at the onset of EAE. All were
immunostained with antibodies against αB-crystallin (cryαB) and Olig2. (h) Changes in optic nerve gene expression of cryαB were addressed by
qPCR, comparing the optic nerve head (ONH) with the distal optic nerve (OND) during AON. There was a significant increase of cryαB mRNA in
the optic nerve head compared to distal segments of optic nerve at day 10 p.i. (n = 11 for healthy and d10 pi optic nerves, and 8 for sham and d7
pi optic nerves); (i) anti-MOG antibody titers in MOG (black line) and sham (red line) immunized animals at different time points (n = 4 per time-
point) were analyzed by ELISA. (j) The binding capacity of anti-MOG antibodies to native huMOG was assessed with 1:400 sera dilutions by flow
cytometry using HEK293 cells transfected with either full length MOG or empty vector, and is depicted as the median fluorescence intensity
(MFI) ratio of HEKMOG versus HEKEV (n = 10 per time-point). *p < .05, **p < .01, ***p < .001, ANOVA. Scale bar = 100 μm
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3.2 | αB-crystallin up-regulation occurs
predominantly within the optic nerve head
To determine whether increased oligodendrocyte αB-crystallin expres-
sion was uniformly distributed or whether it was restricted to specific
anatomical regions of the optic nerve, optic nerves were carefully dis-
sected together with the eye to obtain longitudinal sections containing a
complete optic nerve head (Figure 3a). Sections were then stained with
antibodies against αB-crystallin and Olig2. Focus was made on the initial
myelinated region of the optic nerve head and was compared with more
distal regions of the optic nerve. Although both regions had elevated tis-
sue staining at day 1 of EAE (Figure 3d,g), at day 10 p.i., only the optic
nerve heads had elevated staining (Figure 3c). This was confirmed by
qPCR analysis of αB-crystallin mRNA levels isolated from approximately
1 mm thick optic nerve tissue segments to enrich for the optic nerve
heads in comparison with similar sized optic nerve pieces dissected from
a more distal position (Figure 3h; at day 10, the optic nerve head had
αB-crystallin relative to β-actin of 0.08  0.01 compared to the distal
optic nerve with a value of 0.03  0.007, p = .03, Mann–Whitney).
Since we have previously reported that the optic nerve head dur-
ing AON is more susceptible to deposition of (autoimmune) antibody
(Fairless et al., 2012), we next wished to determine if there was a cor-
relation between IgG deposition and αB-crystallin expression. Anti-
MOG antibody levels were assessed in sera samples taken during the
FIGURE 4 αB-crystallin expression correlates with areas of anti-MOG antibody deposition. Immunohistochemistry of optic nerve sections from
animals 10 days following immunization with either (a, b, e, f ) sham or (c, d, g, h) MOG. Optic nerve head (ONH; a, c, e, g) and distal optic nerve
(OND; b, d, f, h) were stained with antibodies against (a–d) IgG deposition and myelin basic protein (MBP); and (e–h) IgG deposition and αB-
crystallin (cryαB). Single channel images of IgG deposition are shown in a'–h'. (i, j) Serial optic nerve sections from a distal segment of optic nerve
taken from an animal at day 1 of EAE, stained against (i) IgG deposition, cryαB, and DAPI; and (j) IgG deposition and MBP. White arrow in i and j
indicates location of an inflamed blood vessel. Scale bars (h') = 100 μm, (j) = 50 μm
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progression of AON. These increased as the disease progressed in
MOG-immunized rats, but not in those receiving sham-immunization,
becoming significantly elevated at day 10 p.i. (Figure 3i; 0.96 +/− 0.09 at
d0 p.i. vs. 159.45 +/− 15.27 at d10 p.i., p < .001, ANOVA). Similarly, sig-
nificantly elevated anti-MOG titers were detected at day 10 p.i.
(Figure 3j; MFI ratio 7.54  2.41, compared to 1.08  0.04 at d0 p.i.;
p = .0098, ANOVA) using flow cytometry to assess the binding capacity
of anti-MOG antibodies to huMOG-expressing HEK cells, demonstrating
their ability to bind the fully folded native confirmation of human MOG.
Thus, increases in anti-MOG antibody levels correlate with the time-
point that increases in αB-crystallin expression became significant
(Figures 2b and 3h). Immunohistochemical staining of optic nerve head
and distal optic nerve tissue sections demonstrated αB-crystallin eleva-
tion at day 10 post immunization in the optic nerve heads of MOG-
immunized rats (Figure 4g) but not sham-immunized rats (Figure 4e). This
correlated with the same regions displaying observable IgG deposition
(Figure 4c',g'). Similarly, in distal optic nerves where no IgG deposition
was seen, αB-crystallin expression was not easily visible. However, in
later disease sections (Figure 4i, j; day 1 EAE) when the blood–brain bar-
rier of the optic nerve breaks down permitting entry of infiltrating
immune cells (note high density of DAPI-labeled nuclei in Figure 4i), areas
of IgG deposition could be seen in the vicinity of what is probably a
disrupted blood vessel permitting antibody entry. A decrease in myelin
staining could also be seen in this area.
3.3 | Passive transfer of sera results in αB-crystallin
upregulation
Next, to determine if blood-borne factors, such as circulating autoanti-
bodies, were able to induce an up-regulation in αB-crystallin expres-
sion, oligodendrocyte progenitors were isolated from cortices and
cultured in vitro. Afterward, the progenitors were differentiated into
mature oligodendrocytes, as observed by their extension of numerous
processes and confirmed by immunostaining for the myelin compo-
nents CNPase and MOG (Figure 5a,b). Mature oligodendrocytes were
then either left untreated (control) or treated with H2O2 or linsido-
mine (Sin-1, a NO donor) for 90 min followed by overnight recovery
to induce oxidative stress. This resulted in pronounced up-regulation
of αB-crystallin expression as assessed by immunocytochemistry.
Next, mature oligodendrocytes were treated with sera obtained from
FIGURE 5 Treatment with EAE sera from MOG immunized rats leads to increased expression of αB-crystallin in primary oligodendrocyte
cultures. Immunocytochemistry showing mature oligodendrocytes expressing (a) CNPase and (b) MOG (red), co-stained with Olig2 (green).
Immunocytochemistry of oligodendrocytes with CNPase (red) and αB-crystallin (cryαB; green) following (c) no treatment, or 90 min in (d) 100 μM
H2O2 and (e) 100 μM Sin-1 as positive controls for stress. Treatment with sera from (f, h) sham and (g, i) MOG immunized rats led to increased
expression of cryαB (green). (j) Western blot and quantification revealed significant elevation of cryαB in MOG sera-treated cultures than sham
(n = 5 treated cultures for 1% serum treatment and n = 3 treated cultures for 10% serum treatment). Scale bar = 50 μm. *p < .05, Student's t-test
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either sham-immunized (d14 p.i.) or MOG-immunized (d1 EAE) animals
at the indicated dilution in culture media for 90 min. Although some
up-regulation of αB-crystallin was detectable following treatment with
sham sera, this was much higher following treatment with EAE sera
(Figure 5f–i) and was confirmed by Western blot (Figure 5j; 1% sham
(0.48  0.1) vs. 1% EAE sera (0.99  0.1), p = .007; 10% sham
(1.12  0.11) vs. 10% EAE sera (1.59  0.1), p = .039; paired t tests).
To determine the influence of anti-MOG antibodies on αB-crystallin
expression, we next depleted EAE serum of anti-MOG antibodies using
MOG-conjugated Sepharose resin. Confirmation of antibody depletion
FIGURE 6 Anti-MOG antibodies are necessary for EAE sera to induce αB-crystallin upregulation in primary oligodendrocyte cultures. (a) ELISA of
anti-MOG antibody titers demonstrates efficacy of anti-MOG antibody depletion. (b–d) EAE serum, but not that depleted of anti-MOG
antibodies, is able to immunolabel unfixed oligodendrocytes (red, anti-IgG; green, olig2). (e–g) Oligodendrocyte cultures exposed to 1% sera for
90 min followed by overnight recovery were immunolabeled with antibodies against CNPase (red) and αB-crystallin (cryαB, green). (h) Western
blot with quantification showing upregulation of αB-crystallin following 90 min exposure to 1% EAE serum, but not with EAE serum depleted of
anti-MOG antibodies. (i) Reactive oxygen species were quantified in oligodendrocyte cultures using CellROX assay. Cells exposed to H2O2 had
increased ROX positivity, but not cells exposed to 1% serum. Overnight exposure of cells to 10% serum or H2O2 served as positive controls.
(j) Oligodendrocyte toxicity was assessed using a fixable LIVE/DEAD assay demonstrating increased cell death upon exposure to H2O2, and also
EAE serum when exposed overnight. (k) Lentiviral delivery of shRNA against αB-crystallin successfully reduced αB-crystallin expression in
oligodendrocyte cultures compared to delivery of a scrambled control (SCR) shRNA sequence. All cultures were exposed to 10% EAE serum for
90 min followed by overnight recovery. (l) Oligodendrocytes treated with shRNA targeting αB-crystallin had increased cell death upon 90 min
exposure to 1% EAE sera compared to those treated with scrambled shRNA, or exposure to sham sera. Dashed line indicates the untreated
control levels (as shown in panel j). Scale bar = 50 μm; *p < .05, **p < .01, ANOVA
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was assessed by MOG-ELISA (Figure 6a) as well as staining of fully differ-
entiated oligodendrocyte cultures with sera (Figure 6b–d). Only sera
containing anti-MOG antibodies were able to immunolabel oligoden-
drocytes, but not sham sera or EAE sera following depletion of the anti-
MOG antibody fraction. Oligodendrocytes were next exposed to the
sera samples for 90 min followed by overnight recovery, to mimic the
“sublytic” conditions of the preclinical environment (i.e., presence of
antibody but no oligodendrocyte death/myelin loss; Figures 1b,e,g and
3i). Both immunolabeling and Western Blot demonstrated an upregula-
tion of αB-crystallin in oligodendrocytes which were exposed to EAE
serum, but not following depletion of anti-MOG antibodies (1% EAE
serum, 1.22  0.08; 1% EAE serum depleted of anti-MOG antibodies,
0.64  0.13; p = .012, ANOVA; Figure 6h). Analysis of reactive oxygen
species, a key component of tissue injury in inflammatory demyelinating
lesions (Lassmann, 2014), as well as cell survival, was then performed.
Reactive oxygen species levels were elevated in controls (exposure to
H2O2 or overnight incubation in EAE serum) but not under sublytic
conditions (Figure 6i). Similarly, cell death was not induced in oligoden-
drocytes exposed to sublytic sera conditions (Figure 6j).
In order to further our understanding regarding the function of
αB-crystallin upregulation, we next used shRNA to knock-down its
expression. Treatment of oligodendrocyte cultures with lentiviral par-
ticles carrying shRNA constructs previously demonstrated to reduce
αB-crystallin expression (Gangalum, Bhat, Kohan, & Bhat, 2016) simi-
larly reduced expression of αB-crystallin in cultures which were trea-
ted with EAE sera (Figure 6k). Cell survival of lentiviral-transfected
oligodendrocyte cultures was then assayed following exposure to
sera. As before, control cultures were invulnerable to sublytic sera
exposure, however a significant elevation in cell death was observed
in oligodendrocytes which received αB-crystallin shRNA and subse-
quently exposed to EAE serum (control cell death, 2.92  0.44%; SCR
shRNA 2.16  0.16%, cryab shRNA 4.13  0.45%, p = .005; ANOVA;
Figure 6l). Thus knock-down of αB-crystallin sensitized the oligoden-
drocytes to EAE serum-mediated toxicity.
Finally, we wished to determine whether passive transfer of sera
from immunized rats with EAE would be sufficient to induce expres-
sion of αB-crystallin in naïve, unimmunized recipient rats. To achieve
this, sera was collected as before from either sham-immunized
FIGURE 7 Passive transfer of EAE sera results in elevated αB-crystallin expression within the optic nerve head of unimmunized, recipient rats.
Immunohistochemistry of optic nerve head (ONH; a, c, e, g, i, k) and distal optic nerve (OND; b, d, f, h, j, l) regions from representative unimmunized
rats receiving passive transfer by intravenous injection of sham (a–d) or MOG EAE (e–h) sera, or MOG EAE sera that had been depleted of anti-
MOG antibodies (i–l). Immunohistochemistry was performed against deposited IgG with (a, b, e, f, i, j) and without (a0 , b0, e0 , f0, i0 , j0) DAPI counter-
labeling of nuclei, or against αB-crystallin (cryαB, red) and Olig2 (green) (c, d, g, h, k, l). (m) Anti-MOG ELISA was performed on sera samples obtained
from recipient rats. Black line indicates the level of αMOG antibody in sham immunised donor rats (day 14 p.i.). Scale bars = 100 μm
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(d14 p.i.) or MOG-immunized rats (d1 EAE) and injected intrave-
nously. Anti-MOG antibody titers were then measured in sera sam-
ples taken from recipient animals as an indicator of successful
transfer. Rats receiving sham sera had negligible anti-MOG titers, as
assessed by ELISA, whereas this was robustly elevated in rats receiv-
ing EAE sera (Figure 7m). Five days following passive transfer (day
5 pst), recipient rats were perfused and optic nerves were analyzed
for deposition of IgG antibody and αB-crystallin expression. Anti-
body deposition was only seen in the optic nerve heads of rats
receiving EAE sera (Figure 7e0), but not in the distal optic nerve nor
in optic nerves of rats receiving sham sera. Similarly, αB-crystallin
up-regulation was only apparent within the optic nerve heads of
rats receiving EAE sera, where it correlated with the regions of IgG
deposition. To further clarify the impact of anti-MOG antibodies on
αB-crystallin expression in vivo, we repeated passive transfer experi-
ments using EAE sera that had been depleted of anti-MOG anti-
bodies. Similar to that seen in rats receiving sham sera, optic nerve
heads had neither evidence of IgG deposition nor changes in
αB-crystallin expression (Figure 7i,k), demonstrating the requirement
for anti-MOG antibodies to induce upregulation of αB-crystallin.
4 | DISCUSSION
Here we report that an early stress response, as revealed by
αB-crystallin expression, could be detected in oligodendrocytes (and
also astrocytes) during preclinical AON, where it was mostly restricted
to the vicinity of the optic nerve head. It has previously been reported
that the blood–brain barrier is incomplete in this region (Hofman,
Hoyng, vanderWerf, Vrensen, & Schlingemann, 2001; Tso, Shih, &
McLean, 1975), and we previously reported that blood-borne proteins
such as albumin, and also IgG, were able to gain access to the tissue
parenchyma of the optic nerve head (Fairless et al., 2012). Similarly,
we report here that passive transfer of sera from MOG-immunized
animals resulted in IgG deposition within this region, overlapping with
the myelinated regions of axons, thus coming into contact with oligo-
dendrocytes which displayed signs of cellular stress as indicated
by αB-crystallin up-regulation. Similar observations were made in
more distal regions of the optic nerve in the vicinity of disturbed
blood vessels, indicating a similar cellular reaction to the entry of
MOG EAE-specific sera components, which in addition to cytokines
and complement proteins, involve the function of anti-MOG anti-
bodies as indicated by our antibody depletion experiments. The role
that anti-MOG antibodies might be playing in this disease model is
intriguing due to their association with other neurological conditions
such as pediatric MS, neuromyelitis optica in AQP-4 antibody-
negative cases and occasionally anti-NMDA-receptor encephalitis
(Havla et al., 2017). Although the relationship of anti-MOG antibodies
to adult MS has not been so clear, recent studies have reported that
they are strongly associated with bilateral optic neuritis in adults
(Ramanathan et al., 2014). Interestingly, MOG-antibody-associated
optic neuritis was shown to have a strong correlation with optic nerve
head swelling (over 50% of reported patients) which was absent in
MS-associated optic neuritis (Ramanathan et al., 2016). This fits with
the observations we previously reported in rat AON where increased
numbers of activated microglia were particularly apparent in the vicin-
ity of the optic nerve head (Fairless et al., 2012).
At present, it is unclear in our model what the stress response we
report represents—however, due to evidence gleaned from other injury
models, it may well be part of a protective process. αB-crystallin is
up-regulated following various injuries and insults such as stroke and
oxidative damage, as well as in models of neuroinflammation and
age-related macular degeneration (Chis et al., 2012; Fittipaldi et al.,
2015; Goldbaum, Riedel, Stahnke, & Richter-Landsberg, 2009; Ke et al.,
2013; Shao et al., 2013; Zhou et al., 2014). It appears to form part of a
protective reaction to injury since it can act to regulate apoptosis
through interaction with proteins such as p53, Bax, BclXS, and caspase-3
(Hu et al., 2012; Liu, Li, Tao, & Xiao, 2007; Mao, Liu, Xiang, & Li, 2004),
and to modulate the immune response (Bsibsi et al., 2013; Ousman
et al., 2007; Quach et al., 2013). This has been demonstrated in knock-
out mice where a lack of αB-crystallin resulted in exacerbation of EAE,
and similarly, systemic administration of soluble αB-crystallin ameliorated
disease (Ousman et al., 2007). This view is further supported by our
observation that shRNA-mediated knock-down of αB-crystallin rendered
previously invulnerable oligodendrocyte cultures susceptible to toxicity
induced by short exposure to EAE sera.
However, αB-crystallin may also play a detrimental role in dis-
ease development. It was originally reported to potentially be an
autoantigen in MS (van Noort et al., 1995), although subsequent
investigation did not support a clear connection with the pathol-
ogy of either MS or EAE (Van Noort, Verbeek, Meilof, Polman, &
Amor, 2006; Wang et al., 2006). In addition, although αB-
crystallin has been reported to induce a protective microglial
response (Bsibsi et al., 2013), in combination with IFNγ, possibly
deriving from infiltrating T cells, microglia can be reprogrammed
to form a robust pro-inflammatory response, facilitating demye-
lination (Bsibsi et al., 2014). Thus, its function appears to depend
on the immune environment in which it is expressed, and may
reflect an initial protective response during lesion formation, but
later having limited effectiveness or even acting as a driving force
behind the immune response following infiltration of peripheral
immune cells.
In conclusion, we report that αB-crystallin expression reports an
early stress response in oligodendrocytes during the preclinical stage
of AON, which correlates with areas of IgG deposition. This addition-
ally demonstrates that the optic nerve head may represent a region of
particular vulnerability due to its incomplete isolation from the vascu-
lature, and thus may represent an Achilles' heel in the otherwise
immune privileged CNS.
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